Monday, 20 May 2019

You are here

Dr. Olga Petryna - Canakinumab in CVD Pts Prevents Acute Gout Attacks

Dr. Petryna reviews Dr. Dan Solomon's EULAR 2018 plenary presentation showing a 50-60% reduction in acute gout amongst CVD patients treated with canakinumab.

Add new comment

Want to talk about this video? Comment here to lead the discussion.
MORE VIDEOS

Alvin Wells, MD: JAK Inhibitors, Other...

08 Nov 2015

The RheumNow Week in Review – 27...

27 Jan 2017

Dr. Cassie Calabrese: Clinical...

23 Jan 2017

QD Clinic - The Power of Patient Choice

15 Mar 2019

Dr. Rachel Tate: RISE Registry

07 Nov 2017

The Week in Review: 5 February 2016

08 Feb 2016

RheumNow Live Preview with Dr. Len...

22 Apr 2019

Dr. Naomi Schlesinger: Gout Trials

23 Oct 2018

RheumNow Podcast - Death and Surgery (2...

22 Feb 2019

Dr. Rachel T. Huston: Drug Exposure in...

01 Dec 2016

Dr. Arthur Kavanaugh: Predictors

21 Oct 2018

Dr. Jack Cush: Highlights from 2017 in...

09 Feb 2018